Sign in
4

Changes in Ownership

Taysha Gene Therapies, Inc. Filed Acc 0001415889-24-015041

Director acquired 49,220 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Stalfort John A III Director 2024-05-29 Grant or award +49,220 1,098,601 D
Derivatives
Stalfort John A III Director 2024-05-29 Grant or award · Stock Option (right to buy) +98,440 98,440 D
Loading xslF345X05/form4-05312024_040510.xml…